REFRACTORY CHRONIC COUGH
Clinical trials for REFRACTORY CHRONIC COUGH explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC COUGH trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested to quiet unstoppable coughs
Symptom relief CompletedThis study tested whether a new, long-acting tablet called nalbuphine ER could safely reduce the number of coughs per day in people with a persistent cough that hasn't responded to other treatments. It involved 66 adults and compared the active drug to a placebo (a dummy pill) to…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New drug tested to quiet persistent, unexplained coughs
Symptom relief CompletedThis study tested whether a new drug called HRS-2261 could safely reduce the severity of a long-term, unexplained cough. About 100 adults with this condition for over a year took either the drug or a placebo for four weeks. Researchers measured changes in cough severity and quali…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Mar 24, 2026 12:02 UTC